Exploring the effects of GLP-1 receptor agonists in fibromyalgia: a propensity-matched real-world cohort using the TriNetX research platform
At 72 weeks, a significantly higher proportion of patients receiving orforglipron, particularly the 36 mg dose group (54.6%), achieved and surpassed a clinically meaningful body-weight reduction compared to the placebo group (12.9%) with improvement in cardiometabolic risk factors (Table 1) [32]
Saxenda is often much more affordable when it is covered by insurance
Shared Side Effects and Synergy Even though the drugs do not interact chemically, they can produce additive side effects
In addition to per-protocol laboratory analyses, human biosamples for future analysis were retained, as long as participants had signed a separate informed consent form
Im on my third week and I have to say this product works